Inhibitors of fatty acid oxidation for prophylaxis and treatment of diseases related to mitochondrial dysfunction

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

12459227

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

Described are a method and a composition for preventing and/or treating a disease related to mitochondrial dysfunction by inhibiting the fatty acid oxidation of one or more cells of an organism. Particularly, the fatty acid oxidation is inhibited by inhibiting the expression and/or activity of the enzyme Carnitin-Palmitoyl-Transferase-1 (CPT-1) by means of an arylalkyl- or arlyoxyalkyl-substitued oxirane carboxylic acid or pharmaceutically acceptable salts and derivatives of the arylalkyl-substituted oxirane carboxylic acid.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
MEDIGENE AG82152 PLANEGG

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Henkel, Thomas Kassel, DE 40 288
Rehfuess, Christoph Munich, DE 5 24

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation